Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progressive supranuclear palsy.

R Pahwa1

  • 1Department of Neurology, University of Kansas Medical Center, Kansas City, USA.

The Medical Clinics of North America
|March 27, 1999
PubMed
Summary
This summary is machine-generated.

Progressive supranuclear palsy (PSP) is a rare brain disorder. Despite decades of research, its cause, pathogenesis, and effective treatments remain unknown.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.

Nature aging·2026
Same author

Evaluation of morning bradykinesia in Parkinson's disease in a United States cohort using continuous objective monitoring.

Clinical parkinsonism & related disorders·2022
Same author

Dopaminergic Basis of Spatial Deficits in Early Parkinson's Disease.

Cerebral cortex communications·2021
Same author

The effect of the accessory proteins, soluble CD14 and lipopolysaccharide-binding protein on Toll-like receptor 4 activity in human monocytes and adipocytes.

International journal of obesity (2005)·2016
Same author

Insulin resistance and gray matter volume in neurodegenerative disease.

Neuroscience·2014
Same author

Long-term evaluation of gait initiation in six Parkinson's disease patients with bilateral subthalamic stimulation.

Gait & posture·2011

Area of Science:

  • Neurology
  • Neuroscience
  • Clinical Medicine

Background:

  • Progressive supranuclear palsy (PSP) is a rare neurodegenerative disease.
  • First described by Richardson in the 1950s, PSP presents as an unusual clinical syndrome.
  • Despite increased research over 25 years, the etiology and pathogenesis of PSP remain elusive.

Purpose of the Study:

  • To provide a comprehensive review of progressive supranuclear palsy (PSP).
  • To consolidate current knowledge on PSP's epidemiology, clinical presentation, and diagnostic standards.
  • To summarize advancements in understanding PSP's neuropathology, neuroimaging, and therapeutic options.

Main Methods:

  • Literature review of epidemiological studies on PSP.
  • Analysis of clinical case reports and diagnostic criteria evolution.

Related Experiment Videos

  • Synthesis of neuropathological and neuroimaging findings in PSP.
  • Review of existing and experimental treatment strategies for PSP.

    • Main Results:

    • PSP affects individuals with a specific clinical syndrome.
    • Significant progress in understanding PSP's features, but cause and pathogenesis are still unclear.
    • No definitive treatment currently exists for progressive supranuclear palsy.

    Conclusions:

    • PSP remains a challenging disorder with unknown origins.
    • Further research is crucial for understanding PSP pathogenesis and developing effective treatments.
    • This review highlights the current state of knowledge and future research directions for PSP.